絞り込み

16426

広告

959件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

A quantitative LC/MSMS method for determination of edoxaban, a Xa inhibitor, and its pharmacokinetic application in patients after total knee arthroplasty.

Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor Shrinkage.

International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants.

Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial.

The selectivity and bioavailability improvement of novel oral anticoagulants: An overview.

What have we learned from real-world NOAC studies in venous thromboembolism treatment?

Simple method for removing DOACs from plasma samples.

Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin.

Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.

Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies.

Periprocedural Anticoagulation Management for Atrial Fibrillation Ablation: Current Knowledge and Future Directions.

Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab.

Reversal agents for non-vitamin K antagonist oral anticoagulants.

Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation?

Comparison of anticoagulant therapy for atrial fibrillation - novel oral anticoagulants versus vitamin K antagonists.

Stroke Prevention in Atrial Fibrillation - Which is the BEST?: Balanced in Efficacy and Safety as a Thromboprophylactic.

Prothrombin times in the presence of edoxaban - in-vivo experience from King's College hospital.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります